share_log

赛升药业(300485.SZ):前三季度净亏损9819.82万元

Beijing Science Sun Pharmaceutical (300485.SZ): a net loss of 98.1982 million yuan in the first three quarters.

Gelonghui Finance ·  Oct 24, 2024 17:51

On October 24, GeLongHui reported that Beijing Science Sun Pharmaceutical (300485.SZ) released its third quarter report for 2024. In the first three quarters of 2024, the company achieved revenue of 0.323 billion yuan, a decrease of 18.01% year-on-year; the net income attributable to shareholders of the listed company was a loss of 98.1982 million yuan, a decrease of 149.97% year-on-year; the net income after deducting non-recurring gains and losses was 17.5475 million yuan, a decrease of 21.27% year-on-year; and the basic EPS was -0.20 yuan per share.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment